Molecular and Cellular Mechanisms of Cancers: Lymphomas
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (31 January 2020) | Viewed by 250
Special Issue Editor
Interests: leukemia; lymphoma; targeted therapy; molecular diagnostics; high throughput genomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent improvements in our knowledge of the molecular pathogenesis of malignant lymphoma has offered a new rational basis for innovative targeted therapies. However, there is still a consistent gap between the identification of pathways as potential targets and the development of effective therapeutic strategies in this field.
This Special Issue aims to provide new concepts and new ideas on the pathogenesis, genetics, and clinical maintenance of human lymphomas. Not only new experimental findings (diagnostic, clinical, pre-clinical, and translational) but also case series, and review articles (the latter needing a preliminary contact with the Editor before submission), will be considered.
The objective is to eventually favor the translation of genomic and pre-clinical findings into concrete benefits for lymphoma patients.
Prof. Pier Paolo Piccaluga
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lymphoma
- molecular pathogenesis
- molecular diagnosis
- targeted therapy.
